Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ipsen
Pharma
Ipsen touts early launch results for liver disease drug Iqirvo
Ipsen’s Iqirvo is off to a solid launch as it battles with two other drugs to treat patients with the rare liver disease primary biliary cholangitis.
Kevin Dunleavy
Apr 17, 2025 8:47am
Arrowhead, Zevra fire up campaigns for Rare Disease Day 2025
Feb 28, 2025 10:18am
Apellis hit with yet another eye drug snub in Europe
Sep 20, 2024 10:06am
Exelixis plots FDA prostate cancer filing despite survival miss
Sep 16, 2024 5:00pm
Sanofi, DualityBio, UCB—Fierce Pharma Asia
Aug 30, 2024 8:05am
FDA approves Gilead's Livdelzi for primary biliary cholangitis
Aug 14, 2024 3:29pm
